Wednesday, October 20, 2010

Follow-up to Carlat's "Dr. Drug Rep"

In Daniel Carlat's article, "Dr. Drug Rep," which appeared in the New York Times Magazine in November of 2007, Carlat describes his experience of being a "detail man" for the Wyeth antidepressant Effexor. Years ago when investigating patient responses to commonly used antidepressants, I found an online petition to take Effexor off the market, authored and signed by enraged former and current Effexor users. Many of the patient comments echo Carlat's nagging concerns that he was hesitant to mention during his industry-funded "physician education" lunch talks, especially those regarding withdrawal effects. See the petition and patient comments, here.

No comments:

Post a Comment